In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten‐year period against fluconazole, voriconazole and posaconazole (SCH56592)
- 1 November 2002
- Vol. 45 (9-10) , 378-383
- https://doi.org/10.1046/j.1439-0507.2002.00765.x
Abstract
We investigated the in vitro susceptibilities of 213 cerebrospinal fluid isolates of Cryptococcus neoformans isolated from 192 patients through a 10-year period, 1990-99, against fluconazole, voriconazole and posaconazole (SCH56592) by using the NCCLS (National Committee for Clinical Laboratory Standards) macrodilution method, M27-A. The overall MICs50 and MICs90 of fluconazole, voriconazole and posaconazole were found to be 2 and 8 micro g ml-1, <or=0.125 micro g ml-1 (both), and <or=0.015 and 0.06 micro g ml-1, respectively. The MIC ranges, MICs50, and MICs90 of three triazoles were also determined according to the defined year category (1990-94, 1995, 1996, 1997 and 1998-99). The MICs50 and MICs90 of each triazole remained almost unchanged and did not exhibit any sign of an upward shift during a decade (1990-99). However, a tendency for development of possible cross-resistance between the three triazoles was observed only in 1996. Meanwhile, the individual relapsing isolates (n:21) from 20 patients exhibited same, higher or, suprisingly, lower MICs, particularly against fluconazole and posaconazole.Keywords
This publication has 24 references indexed in Scilit:
- Early Mycological Treatment Failure in AIDS‐Associated Cryptococcal MeningitisClinical Infectious Diseases, 1999
- Comparison of broth macrodilution, broth microdilution and E‐test susceptibility tests of Cryptococcus neoformans for fluconazoleMycoses, 1997
- Possible Development of Resistance to Fluconazole During Suppressive Therapy for AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility TestingClinical Infectious Diseases, 1996
- Decreased Fluconazole Susceptibility of a Relapse Cryptococcus neoformans Isolate After Fluconazole TreatmentInfectious Diseases in Clinical Practice, 1995
- Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent MeningitisClinical Infectious Diseases, 1994
- Cryptococcal Meningitis and AIDSClinical Infectious Diseases, 1993
- A Controlled Trial of Fluconazole or Amphotericin B to Prevent Relapse of Cryptococcal Meningitis in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levelsJournal of Infection, 1991
- Cryptococcal Meningitis in Patients with AIDSThe Journal of Infectious Diseases, 1988